In addition to activation of MYC and mTORC signaling, we revealed that pancreatic cancers with HIF-1 high scores were more immunosuppressive by further investigation into the hypoxia-immune profiles. The gene discussed is HIF1A; the disease is familial pancreatic carcinoma.